Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

This study has been terminated.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: June 14, 2006
Last updated: May 15, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)